Physician profile
David Lewis
NPI 1700808938
$1,997.92
in general payments reported to CMS, 2019-2025
18 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $241 · 2021: $308 · 2022: $258 · 2023: $419 · 2024: $137 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $484.04 | 2019-2025 | |
| Aerin Medical INC. | $391.35 | 2022-2025 | |
| Stryker Corporation | $254.42 | 2019-2022 | |
| Allergan, INC. | $253.73 | 2019-2021 | |
| Abbvie INC. | $104.76 | 2021 | |
| Intersect Ent, INC. | $100.42 | 2019-2021 | |
| Genzyme Corporation | $78.37 | 2022-2025 | |
| Kaleo, INC. | $55.88 | 2022-2024 | Auvi-Q |
| Inspire Medical Systems, INC. | $51.40 | 2025 | Inspire |
| Cochlear Americas | $39.03 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Ars Pharmaceuticals Operations, INC. | $39.02 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $36.77 | 2025 | Dupixent |
| Karl Storz Endoscopy-America | $22.44 | 2025 | |
| Glaxosmithkline, LLC. | $20.21 | 2023 | Nucala |
| Medtronic, INC. | $19.47 | 2024 | Pteye Parathyroid Detection System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.44 | 2025 | Xolair |
| Shire North American Group INC | $13.84 | 2019 | |
| Galderma Laboratories, L.P. | $13.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.